Pfizer amyloidosis rival from BridgeBio wins FDA nod
| BPAVX Fund | USD 35.01 0.06 0.17% |
Slightly above 55% of Boston Partners' investor base is interested to short. The analysis of overall sentiment of trading Boston Partners All Cap mutual fund suggests that many investors are impartial at this time. Boston Partners' investing sentiment can be driven by a variety of factors including economic data, Boston Partners' earnings reports, geopolitical events, and overall market trends.
Boston |
BridgeBio Pharma wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizers Vyndaqel. Read more here.
Read at seekingalpha.com
 |
Boston Partners Fundamental Analysis
We analyze Boston Partners' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boston Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boston Partners based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Boston Partners is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Boston Partners All Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Boston Partners mutual fund to make a market-neutral strategy. Peer analysis of Boston Partners could also be used in its relative valuation, which is a method of valuing Boston Partners by comparing valuation metrics with similar companies.
Peers
Boston Partners Related Equities
| HFMDX | Hennessy Cornerstone | 0.69 | ||||
| PARWX | Parnassus Endeavor | 0.28 | ||||
| PARMX | Parnassus Mid | 0.22 | ||||
| BPAIX | Boston Partners | 0.17 | ||||
| GTLOX | Large Cap | 0.53 |
Other Information on Investing in Boston Mutual Fund
Boston Partners financial ratios help investors to determine whether Boston Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Partners security.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |